copper peptide ghk-cu clinical trial wrinkles randomized GHK-Cu: The And The Claims Around It, is a naturally occurring copper-binding tripeptide found in human plasma. Mechanistically, it’s linked to tissue repair signaling, immune Ghk-cu and skin peptides (topical)

The GHK-Cu Optimal Balance Pharmacy compounds is a sterile injectable intended for subcutaneous administration

It is being tested to treat obesity and type 2 diabetes by itself and in combination with semaglutide as cagrilintide/semaglutide ("CagriSema")

The Core Difference: Calm Stability vs

Reducing processed foods and sugar decreases inflammatory load

Peer-reviewed studies demonstrate that GHK-Cu can: Stimulate fibroblast proliferation and collagen synthesis Increase glycosaminoglycan production Support wound contraction and remodeling Reduce oxidative stress and inflammation A major review published in the International Journal of Molecular Sciences describes GHK-Cu as a compound that resets gene expression to a healthier state, influencing over 4,000 human genes involved in tissue repair and anti-inflammatory processes